and recuse FTC Chair Lina Khan from further action against Express Scripts. “We don’t take this step lightly, but ... we cannot let the FTC’s unlawful actions and false information stand,” ...
Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and demanded the agency retract a report saying the industry middlemen ...
NEW YORK, Sept 17 (Reuters) - Pharmacy benefit manager Express Scripts sued the U.S. Federal ... middlemen raise drug costs defamatory. The FTC said in the July report that market consolidation ...
On September 20, the Federal Trade Commission (FTC) filed its first administrative complaint against PBMs under Chair Lina ...
The FTC report, which stemmed from a probe that began more than two years ago, is false, defamatory and unconstitutional, Express Scripts asserts in its complaint. “It is seventy-four pages of ...
Express Scripts said it fully cooperated with the FTC study for more than two years, meeting “extensive demands” for data and information. Cigna’s stock gained 0.3% premarket on Tuesday and ...
Headquartered in North St. Louis County, Express Scripts, a subsidiary of The Cigna Group, is demanding the FTC retract a report it made in July 2024 that said the pharmacy benefit management ...
Express Scripts, Inc. (“Express Scripts”), one of the largest pharmacy benefit managers (PBMs) in the United States, ...
For more than two years, Express Scripts fully cooperated with the FTC study into the PBM industry, meeting the agency's extensive demands for data and information. The FTC's report disregarded ...
Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...
including Express Scripts, that use their market power to overcharge patients. "The FTC has taken unconstitutional actions in ...
Express Scripts, one of the largest pharmacy benefit ... The lawsuit also alleged the FTC “followed prejudice and politics, not evidence or sound economics, and wrongly concluded that PBMs ...
